Log in with your email address username.

×

[Articles] Rituximab and dose-dense chemotherapy for adults with Burkitt’s lymphoma: a randomised, controlled, open-label, phase 3 trial

Addition of rituximab to a short intensive chemotherapy programme improves EFS in adults with Burkitt’s leukaemia or lymphoma.

email